| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |